Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunyan Dong

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Journal of Cancer|January 2, 2024
Mucin1 as a potential molecule for cancer immunotherapy and targeted therapyXiaohan Tong, Chunyan Dong, Shujing Liang
Journal of Colloid and Interface Science|May 12, 2025
A locally-adapted nanoreactor for autophagy inhibition-enhanced cascade starvation-chemodynamic therapyChunhui Wang, Ruihao Li, Chunyan Dong, et al.
Human Mutation|April 30, 2026
Targeting the Vim-PGI<sub>2</sub> Pathway Enhances CD8<sup>+</sup> T Cell-Mediated Antitumor Immunity in Breast CancerHong Quan, Lujing Shao, Qi Li, et al.
Molecules (Basel, Switzerland)|June 2, 2021
Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery SystemsYanting Sun, Yuling Li, Shuo Shi, et al.
Journal of the American Chemical Society|April 1, 2004
Transition-metal-free: a highly efficient catalytic aerobic alcohol oxidation processRenhua Liu, Xinmiao Liang, Chunyan Dong, et al.
Cancers|July 12, 2025
Correction: Ye et al. The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. <i>Cancers</i> 2022, <i>14</i>, 2101Pingting Ye, Lei Feng, Shuo Shi, et al.
Frontiers in Genetics|October 31, 2022
Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-makingSufeng Qiang, Fei Fu, Jianjun Wang, et al.
Cancers|May 14, 2022
The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast CancerPingting Ye, Lei Feng, Shuo Shi, et al.
Frontiers in Immunology|January 5, 2026
Multi-omics profiling unravel the immune landscape diversity by prognostic signatures of immunotherapy response in triple-negative breast cancerRong Chai, Ziting Zhang, Zheng Gong, et al.
Seminars in Cancer Biology|March 27, 2022
Recent advances of nanodrug delivery system in the treatment of hematologic malignanciesQianling Ye, Yun Lin, Ruihao Li, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Journal of Cancer|January 2, 2024
Mucin1 as a potential molecule for cancer immunotherapy and targeted therapyXiaohan Tong, Chunyan Dong, Shujing Liang
Journal of Colloid and Interface Science|May 12, 2025
A locally-adapted nanoreactor for autophagy inhibition-enhanced cascade starvation-chemodynamic therapyChunhui Wang, Ruihao Li, Chunyan Dong, et al.
Human Mutation|April 30, 2026
Targeting the Vim-PGI<sub>2</sub> Pathway Enhances CD8<sup>+</sup> T Cell-Mediated Antitumor Immunity in Breast CancerHong Quan, Lujing Shao, Qi Li, et al.
Molecules (Basel, Switzerland)|June 2, 2021
Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery SystemsYanting Sun, Yuling Li, Shuo Shi, et al.
Journal of the American Chemical Society|April 1, 2004
Transition-metal-free: a highly efficient catalytic aerobic alcohol oxidation processRenhua Liu, Xinmiao Liang, Chunyan Dong, et al.
Cancers|July 12, 2025
Correction: Ye et al. The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. <i>Cancers</i> 2022, <i>14</i>, 2101Pingting Ye, Lei Feng, Shuo Shi, et al.
Frontiers in Genetics|October 31, 2022
Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-makingSufeng Qiang, Fei Fu, Jianjun Wang, et al.
Cancers|May 14, 2022
The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast CancerPingting Ye, Lei Feng, Shuo Shi, et al.
Frontiers in Immunology|January 5, 2026
Multi-omics profiling unravel the immune landscape diversity by prognostic signatures of immunotherapy response in triple-negative breast cancerRong Chai, Ziting Zhang, Zheng Gong, et al.
Seminars in Cancer Biology|March 27, 2022
Recent advances of nanodrug delivery system in the treatment of hematologic malignanciesQianling Ye, Yun Lin, Ruihao Li, et al.
Pageof 11